NEW YORK CITY, NY / ACCESSWIRE / June 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.